Leaflet FUMIX 1.5mg film-coated tablets

Product code:
W71878001
Quantity:
100
Indicated for:
smoking cessation; nicotine dependence
Route of administration:
oral
Substance:
cytisinicline (nicotinic acetylcholine receptor partial agonist)
ATC
N07BA04 — Nervous system | Drugs used in addictive disorders | Drugs used in nicotine dependence
Cytisinicline, also known as cytisine in some countries, is a medicine used to support smoking cessation. It acts on nicotinic receptors in the brain, partly stimulating the same receptor type that nicotine uses. This can reduce cigarette craving and withdrawal symptoms while making smoking less rewarding.

Treatment works best when it is combined with a clear quit plan, behavioural support and strategies to avoid smoking triggers. The exact schedule depends on the product and country, so patients should follow the instructions given by their doctor or pharmacist. Do not double a missed dose and do not extend the course without medical advice.

Before using cytisinicline, tell your doctor if you are pregnant, breastfeeding, have heart disease, high blood pressure, a previous stroke, stomach ulcer, kidney disease or a mental health condition. Also mention all other medicines. Continuing to smoke during treatment may increase unpleasant effects, and nicotine itself remains harmful to the heart and blood vessels.

Possible side effects include nausea, dry mouth, headache, dizziness, irritability, insomnia, unusual dreams, mild palpitations and stomach discomfort. Seek medical help if you develop chest pain, irregular heartbeat, fainting, allergic symptoms, severe anxiety, depression or thoughts of self-harm. The medicine is a tool to help quitting, but follow-up and motivation remain essential.

General data about FUMIX 1.5mg

Substance:
cytisinicline
Date of latest medicines list:
01-06-2026
Product code:
W71878001
Concentration:
1.5mg
Pharmaceutical form:
film-coated tablets
Quantity:
100
Product type:
Generic medicine
Prescription status:
OTC — Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

Manufacturer:
ADAMED PHARMA S.A. - POLONIA
Holder:
ZENIVA, K.S. - REPUBLICA CEHA
Number:
16586/2026/01
Shelf life:
3 years